Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

17%

1 of 6 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A

3(50.0%)

Phase 2

2(33.3%)

Phase 4

1(16.7%)

6Total

N/A(3)

Phase 2(2)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT03615742Phase 4Recruiting

Diesel Exhaust Induces Glucocorticoid Resistance

Role: collaborator

NCT04853550Completed

Long-Term Follow-up After Ventral Hernia Repair With Strattice Mesh

Role: collaborator

NCT01601522Phase 2Completed

Peanut Allergy Oral Immunotherapy Desensitization

Role: collaborator

NCT00232999Phase 2Completed

Efficacy/Safety Study of Nebulized IVX-0142, a Novel Antiallergic Drug, in Mild Allergic Asthma

Role: collaborator

NCT01812798Not ApplicableUnknown

Canadian Peanut Thresholds Study

Role: collaborator

NCT03620422Not ApplicableCompleted

Mannitol-Induced Cough Challenge in Healthy Controls and Subjects With Mild Allergic Asthma

Role: collaborator

NCT01286129Not ApplicableCompleted

Nasal Allergen Challenge in Rhinitic Subjects

Role: collaborator

NCT01520883Completed

Evaluation of Decisional Conflict and Needs Assessment in Asthma Management

Role: collaborator

NCT00243555Unknown

Development of an Algorithm to Better Predict Clinical Responsiveness to Peanut

Role: collaborator

All 9 trials loaded